Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Adherence news

Show

From To
Underestimating necessity for HAART, and concerns about side-effects, leads to low uptake and poor adherence

Poor uptake of highly active antiretroviral therapy (HAART) by HIV-positive patients and low levels of adherence are caused by patients’ underestimation of the need for

Published
28 April 2005
By
Christopher Gadd
Travelling on HAART, particularly to the US, a 'negative practical and emotional experience.'

Fear of disclosure to immigration officials and/or travelling companions is leading to a significant minority of HIV-positive tourists on HAART to stop their treatment whilst

Published
27 April 2005
By
Edwin J. Bernard
BHIVA issues draft 2005 treatment guidelines, calls for comments by May 3rd

A draft version of the 2005 British HIV Association (BHIVA) guidelines were formally introduced by BHIVA’s former president, Professor Brian Gazzard, chair of the guidelines’

Published
26 April 2005
By
Edwin J. Bernard
Adherence in depressed HIV-positive patients improved by antidepressant treatment

Adherence to antiretroviral therapy is improved by antidepressant treatment in depressed HIV-positive patients, according to the results of a retrospective cohort study published in the

Published
17 March 2005
By
Christopher Gadd
Is less than 95% adherence to NNRTIs good enough to lead to viral suppression?

Adherence to nonnucleoside reverse transcriptase inhibitor (NNRTI) regimens does not need to be perfect to push a viral load below 400 copies/mL, according to results

Published
28 February 2005
By
Mark Mascolini
HIV treatment knowledge still patchy among people with HIV in Soweto

Patients with HIV from Soweto, South Africa have a relatively good understanding of HIV/AIDS according to a report in the February 1st issue of the

Published
14 February 2005
By
Theo Smart
NNRTIs more forgiving for occasionally forgetful patients; but are they the best option for patients with major adherence issues?

Individuals who first obtain an undetectable viral load on highly active antiretroviral therapy (HAART) and then adhere to the regimen between 76% and 99% of

Published
22 December 2004
By
Edwin J. Bernard
Combination of antibiotics as effective and safe as co-trimoxazole at preventing infections, but too expensive to use where needed?

A combination of the antibiotics atovaquone and azithromycin is at least as effective and just as safe as the antibiotic co-trimoxazole at preventing serious bacterial

Published
20 December 2004
By
Michael Carter
Short course AZT for breast-feeding mothers: warning of viral rebound when AZT stopped

The use of AZT (zidovudine, Retrovir) by mothers to prevent the transmission of HIV to their babies lowers HIV viral load in breast milk in

Published
03 October 2004
By
Michael Carter
Viral load one month after starting HAART predicts who will be detectable after six months treatment

Measuring viral load a month after starting highly-active antiretroviral therapy (HAART) can strongly predict which individuals will have a viral below 50 copies/ml after six

Published
03 September 2004
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.